Process development provider appointed for CSIR’s anti-rabies antibody
Posted on 03. Nov, 2009 by admin in News-Pharmaceutical
Kentucky BioProcessing has signed an agreement with the Council for Scientific and Industrial Research (CSIR) to develop a commercially efficient process for RabiVirTM, the CSIR’s award-winning anti-rabies antibody developed in a start-up venture with GreenPharmTM.